School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China. bluer
Int J Pharm. 2011 Jan 17;403(1-2):185-91. doi: 10.1016/j.ijpharm.2010.10.013. Epub 2010 Oct 15.
The objective of the present investigation was to explore the potential of the Chitosan Oligosaccharides (COS)-coated NLC (nanostructured lipid carrier) for ocular drug delivery. NLC loaded with flurbiprofen was prepared by melt-ultrasonic method and then coated with COS with a molecular weight of 3000-6000kDa. After coating, the particles reflected spherical morphology with smooth surface under transmission electron microscope (TEM) analysis and a changed zeta potential from -0.446mV to +20.7mV. The ocular bioadhesion property was evaluated by Gamma scintigraphic technique, revealing that the clearance of the formulations labeled with radioactive 99(m)Tc-DTPA was significantly delayed in the presence of COS, and the AUC of the COS-coated formulation had a 7.7-fold increase comparing with non-coated ones. Additionally, enhanced transcorneal penetration was achieved by using the COS coating with a corresponding apparent permeability coefficients (P(app)) which had a 2.4-fold increase comparing with the reference. Consequently, COS coating modified the properties of NLCs and presented a series of notable advantages in ophthalmic application.
本研究旨在探索壳寡糖(COS)包覆的纳米结构脂质载体(NLC)用于眼部药物传递的潜力。采用熔融超声法制备负载氟比洛芬的 NLC,然后用分子量为 3000-6000kDa 的 COS 进行包覆。包覆后,颗粒在透射电子显微镜(TEM)分析下呈现球形形态,表面光滑,zeta 电位从-0.446mV 变为+20.7mV。通过放射性核素 99(m)Tc-DTPA 标记的制剂的γ闪烁显像技术评估眼部生物黏附特性,结果表明在 COS 的存在下,放射性标记制剂的清除率明显延迟,并且 COS 包覆制剂的 AUC 与非包覆制剂相比增加了 7.7 倍。此外,通过使用 COS 涂层可以实现增强的角膜穿透,相应的表观渗透系数(P(app))增加了 2.4 倍。因此,COS 涂层修饰了 NLC 的性质,并在眼部应用中表现出一系列显著的优势。
Nanotechnology. 2010-12-20
Colloids Surf B Biointerfaces. 2010-7-27
Naunyn Schmiedebergs Arch Pharmacol. 2025-4
Mater Today Bio. 2024-9-4
ACS Omega. 2023-9-22